Featured News
news cover
Ajax Therapeutics Receives Orphan Drug Designation from the U.S. FDA for AJ1-11095 for the Treatment of Myelofibrosis
10 hours ago
news cover
Senti Bio Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for SENTI-202 in the Treatment of Adults with Relapsed or Refractory Acute Myeloid Leukemia
10 hours ago
news cover
EpiEndo Pharmaceutical's ERJ Open Research article reports first clinical trial of glasmacinal (EP395) in COPD patients
10 hours ago
news cover
NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO
10 Dec 2025
View more
Global Express
8 hours ago
CVS Health offering measles vaccine to South Carolina residents amid the state's current outbreak
Vaccine
9 hours ago
TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally
9 hours ago
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
Clinical ResultPhase 1ImmunotherapyPhase 2
10 hours ago
Civica To Supply Essential Generic Medicines under Contract Awarded by US Department of Veterans Affairs
10 hours ago
The PHERGuide study demonstrates the utility of circulating tumor DNA for the early detection and real-time monitoring of localized HER2+ breast cancer
Clinical ResultPhase 2Phase 3ASCO
View more
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Hot reports
May 2025 Patent Highlights
May 2025 Patent Highlights
Patsnap Synapse
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
JMC Annotation Spotlight: Analysis of Breakthrough Therapeutics
Patsnap Synapse
Global Drug R&D Express (February 2025)
Global Drug R&D Express (February 2025)
PatSnap Synapse
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.